Evidence map›Paper›PMID 38697781›Full record

ArticleJournal of medical genetics2024

Challenges in developing and implementing international best practice guidance for intermediate-risk variants in cancer susceptibility genes:

Terri Patricia McVeigh, Fiona Lalloo, Ian M Frayling, Andrew Latchford, Katie Snape, Miranda Durkie, Kevin J Monahan, Helen Hanson

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Journal of medical genetics · 2025
    Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Terri Patricia McVeighCancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK terri.mcveigh@gmail.com h.hanson@exeter.ac.uk.ORCID 0000-0001-9201-9216
Fiona LallooClinical Genetics Service, Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Ian M FraylingSt Vincent's University Hospital, Dublin, Ireland.
Andrew LatchfordSt Mark's the National Bowel Hospital and Academic Institute, London, UK.ORCID 0000-0002-8626-188X
Katie SnapeClinical Genetics, St George's University Hospitals NHS Foundation Trust, London, UK.
Miranda DurkieSheffield Diagnostic Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
Kevin J MonahanSt Mark's the National Bowel Hospital and Academic Institute, London, UK.
Helen HansonFaculty of Health and Life Sciences, University of Exeter Medical School, Exeter, UK terri.mcveigh@gmail.com h.hanson@exeter.ac.uk.ORCID 0000-0002-3303-8713

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic Predisposition to DiseaseAdenomatous Polyposis Coli ProteinHumansNeoplasmsPractice Guidelines as TopicAdenomatous Polyposis Coli ProteinAPC protein, humanGenetic CounselingGenetic Predisposition to Disease

Identifiers

PMID38697781
PMCPMC11287630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.